Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00348504 · ClinicalTrials.gov registry record · Phase 3

Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.

A Phase 3 study of Acute Heart Failure, sponsored by Abbott.

Completed
Registry status
Phase 3
Development phase
1,300
Enrollment target
1
Study location

NCT00348504 is a Phase 3 study of Acute Heart Failure that has completed, run by Abbott. The registered enrollment target is 1,300 participants, roughly in line with the 1,290-participant average among 8 other Acute Heart Failure trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00348504, a Phase 3 study of Acute Heart Failure, has completed, sponsored by Abbott.

COMPLETED
Registry status
Phase 3
Development phase
1,300 participants
Enrollment target
1
Study location

Study Summary

The primary objective of the study is to compare the efficacy of levosimendan and dobutamine on all-cause mortality in the 180 days following randomization.

Conditions Studied

Acute Heart Failure

Interventions

  • DRUG levosimendan
  • DRUG dobutamine

Study Locations (1)

Illinois

  • Global Medical Information - Abbott - Abbott Park

Trial Details

FieldValue
Enrollment Target 1,300 participants
Start Date 2003-03
Est. Completion 2005-06
Phase Phase 3

Sponsor

Abbott

181 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00348504

The ClinicalTrials.gov registry entry for NCT00348504 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,290-participant average among 8 other Acute Heart Failure trials with a reported enrollment target. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which levosimendan is the first listed.

NCT00348504 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00348504 about?

NCT00348504 is a clinical study titled "Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.". The primary objective of the study is to compare the efficacy of levosimendan and dobutamine on all-cause mortality in the 180 days following randomization.

What is the current status of trial NCT00348504?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,300 participants. The study started on 2003-03. Estimated completion is 2005-06.

What conditions does trial NCT00348504 study?

This clinical trial studies the following conditions: Acute Heart Failure.

What interventions are being tested in trial NCT00348504?

The interventions under investigation include: levosimendan (DRUG), dobutamine (DRUG).

Who is sponsoring clinical trial NCT00348504?

This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00348504 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Heart Failure

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.